{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:43:56Z","timestamp":1790909036411,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00259-022-06046-7","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:24:48Z","timestamp":1669512288000},"page":"1134-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-8011","authenticated-orcid":false,"given":"Elin","family":"Pauwels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-7469","authenticated-orcid":false,"given":"Sofie","family":"Celen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-1590","authenticated-orcid":false,"given":"Kristof","family":"Baete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Jentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Serdons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-7245","authenticated-orcid":false,"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-7190","authenticated-orcid":false,"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-1577","authenticated-orcid":false,"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"6046_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/dvdy.24226","volume":"244","author":"LH Maguire","year":"2015","unstructured":"Maguire LH, Thomas AR, Goldstein AM. Tumors of the neural crest: common themes in development and cancer. Dev Dyn. 2015;244:311\u201322.","journal-title":"Dev Dyn"},{"key":"6046_CR2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202\u201311.","journal-title":"N Engl J Med"},{"key":"6046_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.23736\/S1824-4785.20.03261-6","volume":"64","author":"E Pauwels","year":"2020","unstructured":"Pauwels E, Van Aerde M, Bormans G, Deroose CM. Molecular imaging of norepinephrine transporter-expressing tumors: current status and future prospects. Q J Nucl Med Mol Imaging. 2020;64:234\u201349.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"6046_CR4","doi-asserted-by":"publisher","first-page":"39S","DOI":"10.2967\/jnumed.116.186833","volume":"58","author":"N Pandit-Taskar","year":"2017","unstructured":"Pandit-Taskar N, Modak S. Norepinephrine transporter as a target for imaging and therapy. J Nucl Med. 2017;58:39S\u201353S.","journal-title":"J Nucl Med"},{"key":"6046_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","volume":"45","author":"Z Bar-Sever","year":"2018","unstructured":"Bar-Sever Z, Biassoni L, Shulkin B, Kong G, Hofman MS, Lopci E, et al. Guidelines on nuclear medicine imaging in neuroblastoma. Eur J Nucl Med Mol Imaging. 2018;45:2009\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR6","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Taieb","year":"2019","unstructured":"Taieb D, Hicks RJ, Hindie E, Guillet BA, Avram A, Ghedini P, et al. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46:2112\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR7","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","volume":"37","author":"E Bombardieri","year":"2010","unstructured":"Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, et al. 131I\/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010;37:2436\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2967\/jnumed.117.193169","volume":"59","author":"N Pandit-Taskar","year":"2018","unstructured":"Pandit-Taskar N, Zanzonico P, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko S, et al. Biodistribution and dosimetry of 18F-meta-fluorobenzylguanidine: a first-in-human PET\/CT imaging study of patients with neuroendocrine malignancies. J Nucl Med. 2018;59:147\u201353.","journal-title":"J Nucl Med"},{"key":"6046_CR9","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1039\/C6SC00197A","volume":"7","author":"BH Rotstein","year":"2016","unstructured":"Rotstein BH, Wang L, Liu RY, Patteson J, Kwan EE, Vasdev N, et al. Mechanistic studies and radiofluorination of structurally diverse pharmaceuticals with spirocyclic iodonium(III) ylides. Chem Sci. 2016;7:4407\u201317.","journal-title":"Chem Sci"},{"key":"6046_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1021\/acschemneuro.0c00074","volume":"11","author":"S Celen","year":"2020","unstructured":"Celen S, Rokka J, Gilbert TM, Koole M, Vermeulen I, Serdons K, et al. Translation of HDAC6 PET imaging using [18F]EKZ-001-cGMP production and measurement of HDAC6 target occupancy in nonhuman primates. ACS Chem Neurosci. 2020;11:1093\u2013101.","journal-title":"ACS Chem Neurosci"},{"key":"6046_CR11","first-page":"S17","volume":"47","author":"K Baete","year":"2020","unstructured":"Baete K, Sevenois M, Pauwels E, Deroose CM. Verification of xSPECT quant for quantitative I-123-mIBG SPECT\/CT imaging. Eur J Nucl Med Mol Imaging. 2020;47:S17\u2013S8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR12","doi-asserted-by":"crossref","unstructured":"Grkovski M, Zanzonico PB, Modak S, Humm JL, Narula J, Pandit-Taskar N. F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation. J Nucl Cardiol. 2022.","DOI":"10.1007\/s12350-021-02813-5"},{"key":"6046_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6046_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00259-016-3516-0","volume":"44","author":"V Lewington","year":"2017","unstructured":"Lewington V, Lambert B, Poetschger U, Sever ZB, Giammarile F, McEwan AJB, et al. 123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel. Eur J Nucl Med Mol Imaging. 2017;44:234\u201341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0969-8051(94)90135-X","volume":"21","author":"PK Garg","year":"1994","unstructured":"Garg PK, Garg S, Zalutsky MR. Synthesis and preliminary evaluation of Para- and meta-[18F]fluorobenzylguanidine. Nucl Med Biol. 1994;21:97\u2013103.","journal-title":"Nucl Med Biol"},{"key":"6046_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00259-020-04830-x","volume":"48","author":"E Pauwels","year":"2021","unstructured":"Pauwels E, Celen S, Vandamme M, Leysen W, Baete K, Bechter O, et al. Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour. Eur J Nucl Med Mol Imaging. 2021;48:313\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.rlu.0000249592.95945.e4","volume":"32","author":"H Jacobsson","year":"2007","unstructured":"Jacobsson H, Hellstrom PM, Kogner P, Larsson SA. Different concentrations of I-123 MIBG and in-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth? Clin Nucl Med. 2007;32:24\u20138.","journal-title":"Clin Nucl Med"},{"key":"6046_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/02841859909177744","volume":"40","author":"H Jacobsson","year":"1999","unstructured":"Jacobsson H, Johansson L, Kimiaei S, Larsson SA. Concentration of 123I-metaiodobenzylguanidine in left and right liver lobes. Findings indicate regional differences in function in the normal liver. Acta Radiol. 1999;40:224\u20138.","journal-title":"Acta Radiol"},{"key":"6046_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/MNM.0000000000000708","volume":"38","author":"A Moreau","year":"2017","unstructured":"Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud C, Mognetti T, et al. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET\/CT: focus on pheochromocytomas. Nucl Med Commun. 2017;38:771\u20139.","journal-title":"Nucl Med Commun"},{"key":"6046_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s00259-019-04332-5","volume":"46","author":"W Noordzij","year":"2019","unstructured":"Noordzij W, Glaudemans A, Schaafsma M, van der Horst-Schrivers ANA, Slart R, van Beek AP, et al. Adrenal tracer uptake by 18F-FDOPA PET\/CT in patients with pheochromocytoma and controls. Eur J Nucl Med Mol Imaging. 2019;46:1560\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6046_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.25200","volume":"62","author":"KA Streby","year":"2015","unstructured":"Streby KA, Shah N, Ranalli MA, Kunkler A, Cripe TP. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy. Pediatr Blood Cancer. 2015;62:5\u201311.","journal-title":"Pediatr Blood Cancer"},{"key":"6046_CR22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2967\/jnumed.115.171710","volume":"57","author":"J Wu","year":"2016","unstructured":"Wu J, Lin SF, Gallezot JD, Chan C, Prasad R, Thorn SL, et al. Quantitative analysis of dynamic 123I-mIBG SPECT imaging data in healthy humans with a population-based metabolite correction method. J Nucl Med. 2016;57:1226\u201332.","journal-title":"J Nucl Med"},{"key":"6046_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6046_CR24","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2967\/jnumed.116.179234","volume":"57","author":"CM Deroose","year":"2016","unstructured":"Deroose CM, Hindie E, Kebebew E, Goichot B, Pacak K, Taieb D, et al. Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions. J Nucl Med. 2016;57:1949\u201356.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-06046-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-06046-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-06046-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T03:05:08Z","timestamp":1676516708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-06046-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6046"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-06046-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was granted by the Ethics Committee Research UZ\/KU Leuven (28 January 2020\/S63142).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.  and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Paul M. Clement received study budget funds from AstraZeneca and was an advisory board member for AbbVie, AstraZeneca, Bayer, BMS, Daiichi-Sankyo, Leo Pharma, Merck Serono, MSD, Rakuten, Takeda, and Vifor Pharma, outside the scope of the submitted work. Christophe M. Deroose has been a consultant for Terumo, Ipsen, Sirtex, Bayer, and PSI CRO outside the scope of the submitted work. There are no other conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}